iSpecimen shares surge 63.04% intraday after launching AI-driven inventory agent to accelerate biospecimen request processing.

iSpecimen surged 63.04% in intraday trading, driven by the launch of its AI-driven inventory agent on March 12, 2026. The tool, integrated into its market platform, utilizes large language models to automate the analysis of biosample requests and match them with available inventory in its global supplier network, aiming to accelerate processing and reduce manual labor. The company, as described in its January 20, 2026 SEC filing, operates an online technology marketplace connecting researchers with biosample suppliers to provide human biosamples and data access for scientific research.